Welcome to our dedicated page for MPTIRT news (Ticker: MPTIRT), a resource for investors and traders seeking the latest updates and insights on MPTIRT stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect MPTIRT's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of MPTIRT's position in the market.
M-tron Industries (RT) extended its previously announced rights offering expiration from April 15, 2026 to 5:00 p.m. ET on April 20, 2026 to facilitate administration. All other terms remain unchanged: 5 Rights required per share, subscription price $59.00 per share, over-subscription privilege available, and no fractional shares.
Exercise notices and payments must be received by Computershare Trust Company, N.A. by the new deadline; holders in street name should contact their brokers. Prospectus supplement filed March 30, 2026 contains full details.
M-tron Industries (NYSE American: MPTI) announced a transferable subscription rights offering to raise approximately $42.7 million to increase financial flexibility and pursue acquisitions, strategic investments and capacity expansion amid rapid shifts in U.S. defense procurement.
Record date is March 27, 2026; rights trade as MPTI RT from March 31 to April 13, 2026 and expire April 15, 2026 at 5:00 p.m. ET. Five rights purchase one share at a price expected at a 10–12% discount to recent VWAP.